Search Tag: GLP-1RA

2024 24 Jul

  Semaglutide emerged as the most frequently prescribed GLP-1 receptor agonist (GLP-1RA) in 2023 by a significant margin. A nationwide study revealed a substantial rise in new GLP-1RA prescriptions over the past decade, especially since 2020.    While semaglutide dominated prescriptions in 2023, the study also noted a shift in the patient...Read more